FDA Inspection 1317038 — Apinya B. Vutikullird, D.O.

Apinya B. Vutikullird, D.O. — FEI 3008483713

The FDA completed an inspection of Apinya B. Vutikullird, D.O. on May 12, 2026 in Long Beach, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 12, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Long Beach, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance